GONG, L., LIAO, B., SHEN, J., ZHAO, J., GONG, Y., LU, X., . . . LI, Y. (2025). Key Points for Quality Management in Phase Ⅰ Clinical Trials of Anti-Tumor Drugs. Zhongliu Fangzhi Yanjiu, 52(5), 347-354. https://doi.org/10.3971/j.issn.1000-8578.2025.24.1178
Chicago-referens (17:e uppl.)GONG, Li, Bin LIAO, Jie SHEN, Juan ZHAO, Yi GONG, Xiaoxiao LU, Huiyao YANG, Sha LI, och Yongsheng LI. "Key Points for Quality Management in Phase Ⅰ Clinical Trials of Anti-Tumor Drugs." Zhongliu Fangzhi Yanjiu 52, no. 5 (2025): 347-354. https://doi.org/10.3971/j.issn.1000-8578.2025.24.1178.
MLA-referens (9:e uppl.)GONG, Li, et al. "Key Points for Quality Management in Phase Ⅰ Clinical Trials of Anti-Tumor Drugs." Zhongliu Fangzhi Yanjiu, vol. 52, no. 5, 2025, pp. 347-354, https://doi.org/10.3971/j.issn.1000-8578.2025.24.1178.
